Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Integral Diagnostics Ltd

IDX.AX ✗ NOT COMPLIANT ☆ Track — members

ASX · Healthcare · Healthcare Facilities & Services ·

Australia Small Cap Analyst: BUY

Last Close

$1.66

▲ +1.32%

Market Cap $620.40M · Vol 1.50M

Key Metrics

P/E Ratio

39.70

FWD: 16.72

Market Cap

$620.40M

Small Cap

Div Yield

5.75%

Semi-annual dividend

EPS Growth

+6.91%

YoY

RSI (14)

56.45

Momentum

Beta

0.73

vs Market

52W High

$2.14

15.04% below

52W Low

$1.37

25.65% above

Volume

1.50M

Avg 1.25M

P/B

1.10

Price-to-book

ROE

6.93%

Return on equity

Free Float

94.49%

Public shares

Shariah Compliance8 STANDARDS

✗ Integral Diagnostics Ltd (IDX.AX) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does IDX.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+2.67%

+4.05%

+13.79%

-4.55%

YTD

-9.06%

-18.95%

-13.61%

-47.90%

Financials & Valuation

TTM · Annual

Total Revenue	$545.73M
Net Income	$15.25M
Revenue Growth (YoY)	+5.56%
Gross Margin	86.05%
Operating Margin	11.58%
Net Profit Margin	2.79%
ROE	6.93%
ROA · ROIC	2.25% · 3.50%

P/E Ratio	39.70
Forward P/E (FY1)	16.72
PEG Ratio	0.06
P/S	0.95
P/B	1.10
P/FCF	16.52
EPS Growth	+6.91%
Outstanding Shares	373.07M

Technical Indicators

50-Day SMA	$1.56
200-Day SMA	$1.66
RSI (14)	56.45
Beta	0.73
52-Week High	$2.14
52-Week Low	$1.37

Volume Today	1.50M
Avg Daily Volume (30D)	1.25M
Relative Volume	1.19x
Volatility (10D)	40.97
Volatility (30D)	31.44
Free Float	94.49%

Analyst Consensus

BUY

Current Price $1.66

Mean Target $2.13

52W Low$1.37 52W High$2.14

Current

Target

$1.37 $2.14

Current Analyst target

+28.32% upside potential · 14 analysts

Identifiers

ExchangeASX

FIGIBBG00B2FQPP8

ISINAU000000IDX2

CountryAustralia

Sub-IndustryMedical & Diagnostic Laboratories

Earnings DateFeb 21, 2027

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

NTRA Natera Inc +0.16% LH Labcorp Holdings Inc -1.39% RDNT RadNet Inc -1.22% LALPATHLAB.NS Dr. Lal PathLabs Ltd -2.48% WGS GeneDx Holdings Corp -1.60%

Company Profile

Integral Diagnostics Limited is an Australia-based provider of medical imaging services across Australia and New Zealand. The principal activity of the Company is the provision of diagnostic imaging services. The Company operates over145 clinics in Australia and New Zealand through various brands, such as Lake Imaging, Capital Radiology, Future Medical Imaging Group (FMIG), The X-ray Group, Direct Radiology, Imaging @ Olympic Park, Lime Avenue Radiology, Imaging Queensland, South Coast Radiology, Radiology Tasmania, Apex Radiology, Capital Radiology, Fowler Simmons Radiology, Astra Radiology, Trinity MRI, SRG Radiology and Horizon Radiology, among others. Lake Imaging offers radiology services to patients throughout Geelong, Central and Western Victoria. Capital Radiology offers a full range of diagnostic imaging services including low-dose digital x-ray, ultrasound, low-dose CT, echocardiography, 3T MRI, mammography, bone densitometry (DEXA), and interventional radiology services.